These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1418845)

  • 1. Questions and answers from controlled clinical trials of antihypertensive therapy in progressive renal disease.
    Kasiske BL
    Am J Hypertens; 1992 Oct; 5(10):778-9. PubMed ID: 1418845
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials.
    Schrier RW; Estacio RO
    Ann Intern Med; 2001 Jul; 135(2):138-9. PubMed ID: 11453714
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for patients. Using a type of blood pressure medicine, angiotensin-converting enzyme inhibitors, to prevent worsening of kidney disease unrelated to diabetes.
    ACE Inhibition in Progressive Renal Disease Study Group
    Ann Intern Med; 2001 Jul; 135(2):S-21. PubMed ID: 11463005
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution of diuretics to the treatment of hypertension in patients with CKD].
    Ura N; Yamaji I
    Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551
    [No Abstract]   [Full Text] [Related]  

  • 5. ONTARGET still OFF-TARGET?
    Lambers Heerspink HJ; de Zeeuw D
    Circulation; 2011 Mar; 123(10):1049-51. PubMed ID: 21357820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive therapy in renal disease and transplantation.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1992 Jul; 10(5):S79-85. PubMed ID: 1403237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 9. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal effects of combined anti-hypertensive treatments].
    Gallieni M; Olivi L; Mezzina N; Cozzolino M; Cusi D
    Recenti Prog Med; 2010 Feb; 101(2):70-7. PubMed ID: 20433005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy for nondiabetic nephropathy.
    Maschio G
    Am J Kidney Dis; 2000 Apr; 35(4):liv-lvi. PubMed ID: 10809659
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiotensin converting enzyme inhibitors in renal diseases].
    Shestakova MV; Kutyrina IM
    Kardiologiia; 2002; 42(9):74-9. PubMed ID: 12494080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective properties of angiotensin-converting enzyme inhibitors: proofs and limits?
    Esnault VL
    Nephron; 2000 Jun; 85(2):183-4. PubMed ID: 10867528
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hypertension.
    Fogo A; Kon V
    Semin Nephrol; 1996 Nov; 16(6):555-66. PubMed ID: 9125800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy for hypertension associated with kidney disease].
    Suzuki H
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
    MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
    [No Abstract]   [Full Text] [Related]  

  • 18. The COOPERATE trial.
    Presne C; Mansour J; Makdassi R; Choukroun G; Fournier A
    Lancet; 2003 Mar; 361(9362):1054; author reply 1055. PubMed ID: 12660076
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current and future medical therapies for CKD (chronic kidney disease)].
    Maruyama S
    Nihon Yakurigaku Zasshi; 2008 Sep; 132(3):166-72. PubMed ID: 18787299
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.